$237 Million is the total value of PURA VIDA INVESTMENTS, LLC's 75 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 65.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CI | Sell | CIGNA CORPORATION | $8,414,000 | +2.2% | 57,500 | -5.7% | 3.55% | -24.4% |
| TFX | Sell | TELEFLEX INC | $7,230,000 | +1.2% | 55,000 | -4.3% | 3.05% | -25.1% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $6,177,000 | -9.3% | 335,000 | -19.3% | 2.61% | -32.9% |
| PFE | Sell | PFIZER INC | $5,891,000 | -3.8% | 182,500 | -6.4% | 2.49% | -28.8% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $5,078,000 | -37.2% | 42,500 | -34.4% | 2.14% | -53.6% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $4,601,000 | -5.9% | 210,000 | -32.3% | 1.94% | -30.4% |
| LLY | Sell | LILLY ELI & CO | $2,907,000 | -21.5% | 34,500 | -22.0% | 1.23% | -41.9% |
| ARAY | Sell | ACCURAY INC | $2,903,000 | -18.6% | 430,000 | -39.8% | 1.22% | -39.8% |
| AFFX | Sell | AFFYMETRIX INC | $2,616,000 | +9.4% | 259,309 | -7.4% | 1.10% | -19.1% |
| KITE | Sell | KITE PHARMA INC | $2,554,000 | -5.9% | 41,450 | -15.0% | 1.08% | -30.4% |
| QGEN | Sell | QIAGEN NV | $2,175,000 | -0.8% | 78,668 | -7.4% | 0.92% | -26.7% |
| SGYPQ | Sell | SYNERGY PHARMACEUTICALS DEL | $2,114,000 | -0.3% | 372,800 | -6.8% | 0.89% | -26.3% |
| SYK | Sell | STRYKER CORP | $2,091,000 | -70.4% | 22,500 | -70.0% | 0.88% | -78.1% |
| AKRXQ | Sell | AKORN INC | $1,063,000 | -25.7% | 28,500 | -43.2% | 0.45% | -45.0% |
| SPNC | Sell | SPECTRANETICS CORPcall | $301,000 | -91.2% | 20,000 | -93.1% | 0.13% | -93.5% |
| EVAR | Exit | LOMBARD MED INC | $0 | – | -52,875 | -100.0% | -0.11% | – |
| CPRX | Exit | CATALYST PHARM PARTNES INC | $0 | – | -100,129 | -100.0% | -0.17% | – |
| PTCT | Exit | PTC THERAPEUTICS INCcall | $0 | – | -15,000 | -100.0% | -0.23% | – |
| DYAX | Exit | DYAX CORP | $0 | – | -23,500 | -100.0% | -0.26% | – |
| FEIC | Exit | FEI CO | $0 | – | -10,000 | -100.0% | -0.42% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -135,000 | -100.0% | -0.43% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -58,750 | -100.0% | -0.45% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -25,800 | -100.0% | -0.59% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -28,000 | -100.0% | -0.68% | – |
| ZLTQ | Exit | ZELTIQ AESTHETICS INC | $0 | – | -50,000 | -100.0% | -0.91% | – |
| EWA | Exit | ISHARESput | $0 | – | -100,000 | -100.0% | -1.02% | – |
| BCR | Exit | BARD C R INC | $0 | – | -10,000 | -100.0% | -1.06% | – |
| SNN | Exit | SMITH & NEPHEW PLCspdn adr new | $0 | – | -55,000 | -100.0% | -1.10% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -18,000 | -100.0% | -1.36% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -17,500 | -100.0% | -1.42% | – |
| BXLT | Exit | BAXALTA INC | $0 | – | -80,000 | -100.0% | -1.44% | – |
| WMGIZ | Exit | WRIGHT MEDICAL GROUP RIGHTSright 03/01/2019 | $0 | – | -585,836 | -100.0% | -1.51% | – |
| PRGO | Exit | PERRIGO CO PLC | $0 | – | -17,500 | -100.0% | -1.57% | – |
| ALIM | Exit | ALIMERA SCIENCES INCcall | $0 | – | -1,250,000 | -100.0% | -1.58% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -247,500 | -100.0% | -1.59% | – |
| VAR | Exit | VARIAN MED SYS INC | $0 | – | -40,000 | -100.0% | -1.68% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -80,000 | -100.0% | -1.84% | – |
| CYBX | Exit | CYBERONICS INC | $0 | – | -60,000 | -100.0% | -2.08% | – |
| HOLX | Exit | HOLOGIC INCcall | $0 | – | -100,000 | -100.0% | -2.23% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -23,125 | -100.0% | -2.35% | – |
| T107PS | Exit | WRIGHT MEDICAL GROUP INC | $0 | – | -210,101 | -100.0% | -2.52% | – |
| JNJ | Exit | JOHNSON & JOHNSONput | $0 | – | -50,000 | -100.0% | -2.66% | – |
| SNN | Exit | SMITH & NEPHEW PLCcall | $0 | – | -150,000 | -100.0% | -3.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.